A retrospective cohort study comparing the real-world effectiveness outcomes between early-targeted Fidaxomicin or oral Vancomycin treatments in patients with infections due to Clostridioides Difficile
Latest Information Update: 25 Jan 2021
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 25 Jan 2021 New trial record
- 17 Jan 2021 Results published in the Pharmacotherapy